Comparison of Outcomes for Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer Treated With Induction Chemotherapy Followed By Concurrent Chemoradiation vs. Concurrent Chemoradiation Alone

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 779-785

  Huang, Eugene H ^a   Liao, Zhongxing ^a   Cox, James D ^a   Guerrero, Thomas M ^a   Chang, Joe Y ^a   Jeter, Melinda ^a   Borghero, Yerko ^a   Wei, Xiong ^a   Fossella, Frank ^a   Herbst, Roy S ^a   Blumenschein Jr , George R ^a   Moran, Cesar ^a   Allen, Pamela K ^a   Komaki, Ritsuko ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Chemoradiation; Induction chemotherapy; Non small cell lung cancer

Indexed keywords

CHEMOTHERAPY; HISTOLOGY; PATIENT TREATMENT; TUMORS;

ADENOCARCINOMA; CONCURRENT CHEMORADIATION; INDUCTION CHEMOTHERAPY; NON SMALL CELL LUNG CANCER;

ONCOLOGY;

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; VINBLASTINE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DRUG THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME;

EID: 34249340142     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.002     Document Type: Article

References (20)

1. Dillman R.O., Herndon J., Seagren S.L., et al. Improved survival in stage III non-small cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
2. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
3. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
4. Curran W., Scott C., Langer C.J., et al. Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer: Initial report of RTOG 9410. [Abstract]. Proc Am Soc Clin Oncol 19 (2000) 484a
5. Zatloukal P.V., Petruzelka L., Zemanova M., et al. Concurrent versus sequential radiochemotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: Randomized study. Lung Cancer 46 (2004) 87-98
6. Pfister D.G., Johnson D.H., Azzoli C.G., et al. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: Update 2003. J Clin Oncol 22 (2004) 330-353
7. Harris E., and Albert A. Survivorship analysis for clinical studies (1991), Dekker, New York
8. Komaki R., Scott C.B., Sause W.T., et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in RTOG 88-08/ECOG 4588. Int J Radiat Oncol Biol Phys 39 (1997) 537-544
9. Fisher M.D., and D'Orazio A. Concurrent chemoradiotherapy followed by consolidation docetaxel in stage IIIB non-small cell lung cancer (SWOG 9504). Clin Lung Cancer 2 (2000) 25-26
10. Libshitz H.I., McKenna R.J., and Mountain C.F. Patterns of mediastinal metastases in bronchogenic carcinoma. Chest 90 (1986) 229-232
11. Line D.H., and Deeley T.J. The necropsy findings in carcinoma of the bronchus. Br J Dis Chest 65 (1971) 238-242
12. Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to Gefitinib. N Engl J Med 350 (2004) 2129-2139
13. Belani C.P., Choy H., Bonomi P., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5885
14. Vokes E.E., Herndon J.E., Kelley M.J., et al. Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial. [Abstract]. Proc Am Soc Clin Oncol 22 (2004) 618s
15. Liao Z., Komaki R., Stevens C., et al. Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small cell lung cancer. Int J Radiat Oncol Biol Phys 53 (2002) 558-565
16. Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared to once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 (1999) 265-271
17. Saunders M.I., Dische S., Barrett A., et al. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small cell lung cancer: An interim report. CHART Steering Committee. Br J Cancer 73 (1996) 1455-1462
18. Belani C.P., Wang W., Johnson D.H., et al. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small cell lung cancer. J Clin Oncol 23 (2005) 3760-3767
19. Komaki R., Seiferheld W., and Curran W. Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer: Analysis of failures in a phase III study (RTOG 9410). [Abstract]. Int J Radiat Oncol Biol Phys 48 Supp. 1 (2000) 113
20. Vokes E., Herndon J., Crawford J., et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and Leukemia Group B Study 9431. J Clin Oncol 20 (2002) 4191-4198